• In late June 2026, Vicor Corporation was removed from several Russell 2000 indexes and added to the Russell 1000, Russell Midcap, and related growth and dynamic benchmarks, reflecting a shift from small-cap to larger-cap index inclusion.
• At the same time, analysts raised earnings estimates for Vicor, suggesting that improving expectations for its modular power business coincided with its move into higher-profile Russell indexes.
• We’ll now explore how Vicor’s transition into larger Russell indexes shapes its existing investment narrative around AI power and licensing.

Find 44 companies with promising cash flow potential yet trading below their fair value.

Vicor Investment Narrative Recap

To own Vicor today, you have to believe its AI focused power and licensing story can justify a premium valuation and volatile earnings. The index move into the Russell 1000 and Midcap families lifts its profile but does not materially change the near term catalyst, which still centers on execution in AI power modules, or the key risk around lumpy licensing income and underutilized fab capacity.

The most relevant recent development is the wave of analyst earnings estimate increases, which arrived alongside Vicor’s shift into larger Russell indexes. That combination ties the index upgrade to improving expectations for IP royalties and AI related product revenue, but it does not remove the risk that heavy insider selling and a rich earnings multiple could magnify any disappointment if those expectations prove too optimistic.

Yet beneath the AI excitement, investors should be aware that Vicor’s reliance on high margin licensing and litigation means ...

Vicor’s narrative projects $1.3 billion revenue and $416.1 million earnings by 2029. This requires 45.7% yearly revenue growth and a $279.4 million earnings increase from $136.7 million today.

Uncover how Vicor's forecasts yield a $406.25 fair value, a 44% upside to its current price.

Exploring Other Perspectives

Before this index news, the most pessimistic analysts were only looking for revenue of about US$552 million and earnings of roughly US$111 million by 2029, so if you think Vicor’s unique AI power position really is essential for hyperscalers, their cautious view of slower fab fill and licensing growth may feel too restrained.

Explore 3 other fair value estimates on Vicor - why the stock might be worth 30% less than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Vicor research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Vicor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Vicor's overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.